A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Kidney Transplant Recipients
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and safety of Prograf extended
release(XL) plus MMF with Prograf plus MMF in de novo kidney transplant recipients.